Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Ruilope

Showing results (61-70 of 284) with videos related to

Pageof 29
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 22, 2001
Blood pressure control and benefits of antihypertensive therapy: does it make a difference which agents we use?L M Ruilope, E L Schiffrin
Current Opinion in Nephrology and Hypertension|November 1, 1993
Clinical relevance of proteinuria and microalbuminuriaL M Ruilope, J L Rodicio
Hipertension Y Riesgo Vascular|April 23, 2017
Microvascular injury and the kidney in hypertensionG Ruiz-Hurtado, L M Ruilope
Blood Pressure|February 2, 2002
Renal participation in cardiovascular risk in essential hypertensionL M Ruilope, J L Rodicio
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 1, 1993
Angiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertensionJ L Rodicio, L M Ruilope
Hipertension Y Riesgo Vascular|March 4, 2016
[SPRINT study in clinical practice: The goal is to change control blood pressure?]L M Ruilope, J R Banegas
Drugs|January 1, 1993
The kidney and arterial hypertensionL M Ruilope, C Campo, V Lahera
Medicina Clinica|May 17, 2000
[Uric acid and arterial hypertension]J García Puig, L M Ruilope Urioste
Journal of Hypertension|November 18, 2000
Renal implications of the renin-angiotensin-aldosterone system blockade in heart failureL M Ruilope, V Barrios, M Volpe
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|January 11, 2005
Influence of chronic kidney disease development and renin-angiotensin system inhibition on cardiovascular prognosisJ Segura, C Campo, L M Ruilope
Pageof 29

Showing results (61-70 of 284) with videos related to

Sort By:
Pageof 29
Hypertension (Dallas, Tex. : 1979)|September 22, 2001
Blood pressure control and benefits of antihypertensive therapy: does it make a difference which agents we use?L M Ruilope, E L Schiffrin
Current Opinion in Nephrology and Hypertension|November 1, 1993
Clinical relevance of proteinuria and microalbuminuriaL M Ruilope, J L Rodicio
Hipertension Y Riesgo Vascular|April 23, 2017
Microvascular injury and the kidney in hypertensionG Ruiz-Hurtado, L M Ruilope
Blood Pressure|February 2, 2002
Renal participation in cardiovascular risk in essential hypertensionL M Ruilope, J L Rodicio
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 1, 1993
Angiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertensionJ L Rodicio, L M Ruilope
Hipertension Y Riesgo Vascular|March 4, 2016
[SPRINT study in clinical practice: The goal is to change control blood pressure?]L M Ruilope, J R Banegas
Drugs|January 1, 1993
The kidney and arterial hypertensionL M Ruilope, C Campo, V Lahera
Medicina Clinica|May 17, 2000
[Uric acid and arterial hypertension]J García Puig, L M Ruilope Urioste
Journal of Hypertension|November 18, 2000
Renal implications of the renin-angiotensin-aldosterone system blockade in heart failureL M Ruilope, V Barrios, M Volpe
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|January 11, 2005
Influence of chronic kidney disease development and renin-angiotensin system inhibition on cardiovascular prognosisJ Segura, C Campo, L M Ruilope
Pageof 29